- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Schizophrenia; Bipolar disorder
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Aripiprazole – July 2018
Aripiprazole: Powder for injection 400 mg (as monohydrate) with diluent, pre-filled syringe; Abilify
Last updated
26 October 2018